Reactive Oxygen Species and <i>H. pylori</i> Infection: A Comprehensive Review of Their Roles in Gastric Cancer Development
Gastric cancer (GC) is the fifth most common cancer worldwide and makes up a significant component of the global cancer burden. <i>Helicobacter pylori</i> (<i>H. pylori</i>) is the most influential risk factor for GC, with the International Agency for Research on Cancer class...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
MDPI AG,
2023-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Gastric cancer (GC) is the fifth most common cancer worldwide and makes up a significant component of the global cancer burden. <i>Helicobacter pylori</i> (<i>H. pylori</i>) is the most influential risk factor for GC, with the International Agency for Research on Cancer classifying it as a Class I carcinogen for GC. <i>H. pylori</i> has been shown to persist in stomach acid for decades, causing damage to the stomach's mucosal lining, altering gastric hormone release patterns, and potentially altering gastric function. Epidemiological studies have shown that eliminating <i>H. pylori</i> reduces metachronous cancer. Evidence shows that various molecular alterations are present in gastric cancer and precancerous lesions associated with an <i>H. pylori</i> infection. However, although <i>H. pylori</i> can cause oxidative stress-induced gastric cancer, with antioxidants potentially being a treatment for GC, the exact mechanism underlying GC etiology is not fully understood. This review provides an overview of recent research exploring the pathophysiology of <i>H. pylori</i>-induced oxidative stress that can cause cancer and the antioxidant supplements that can reduce or even eliminate GC occurrence. |
|---|---|
| Item Description: | 10.3390/antiox12091712 2076-3921 |